Marián Mokáň

Marián Mokáň

Auto-generated profile, based on publicly available information

Marián Mokáň

Clinic of Internal Medicine I., Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollárova 2, Martin, 036 59, Slovak Republic

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
MMMarián Mokáň
Marián Mokáň
PGPeter Galajda
Peter Galajda
DPDana Prídavková
Dana Prídavková
VTViera Tomášková
Viera Tomášková
ĽŠĽudovít Šutarík
Ľudovít Šutarík
GRGabriela Rusnáková
Gabriela Rusnáková

8 May 2017 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MSMatej Stančík
Matej Stančík
ISIvana Ságová
Ivana Ságová
EKEma Kantorová
Ema Kantorová
MMMarián Mokáň
Marián Mokáň
The role of vaspin in the pathogenesis of stable coronary artery disease (SCAD) have been repeatedly addressed in clinical studies. However, from the point of view of clinical practice, the results of earlier studies are still inconclusive. The data of 106 SCAD patients who received coronary angiography and 85 coronary artery disease-free controls were collected and analysed. The patients were divided into subgroups according to their pre-test probability (PTP) and according to the result of coronary angiography. Fasting vaspin concentrations were compared between subgroups of SCAD patients and between target group and controls. The effect of age and smoking on the result of coronary angiography was compared to the effect of vaspin using the binomial regression. We did not find significant difference in vaspin level between target group and controls. Unless the pre-test probability was taken into account, we did not find vaspin difference in the target group, when dividing patients on the basis of presence/absence of significant coronary stenosis. In the subgroup of SCAD patients with PTP between 15% – 65%, those with significant coronary stenoses had higher mean vaspin concentration (0,579 ± 0,898 ng/ml) than patients without significant stenoses. (0,379 ± 0,732 ng/ml) (t = −2595; p = 0,012; d = 0,658; 1-β = 0,850). Age, smoking status and vaspin significantly contributed to the HSCS prediction in binomial regression model in patients with low PTP (OR: 1.1, 4.9, 8.7, respectively). According to our results, vaspin cannot be used as an independent marker for the presence of CAD in general population. However, our results indicate that measuring vaspin in SCAD patients might be clinically useful in patients with PTP below 66%.

4 August 2016
Verified
Journal Article
Closed access
AKAdriana Klimentová
Adriana Klimentová
ISIvana Ságová
Ivana Ságová
DPDana Prídavková
Dana Prídavková
DKDaniela Kantárová
Daniela Kantárová
PMPavol Makovický
Pavol Makovický
MMMarián Mokáň
Marián Mokáň

1 April 2008
Verified
Journal Article
Closed access
MMM Mokán
M Mokán

1 April 2016
Verified
Journal Article
Closed access
DPDana Prídavková
Dana Prídavková
DKDaniela Kantárová
Daniela Kantárová
RLRenáta Lišková
Renáta Lišková
PČPeter Červeň
Peter Červeň
FKFrantišek Kovář
František Kovář
MMMarián Mokáň
Marián Mokáň

23 January 2016
Verified
Journal Article
Closed access
MMMichal Mokáň
Michal Mokáň
PGPeter Galajda
Peter Galajda
MMMarián Mokáň
Marián Mokáň